Search - tctmd.com

Displaying 141 - 151 of 151

Sort: Relevancy | Date

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

Presentation CATCH-UP 2015

Right Heart Failure After LVAD

Presenter: Maryjane Farr

April 25, 2015

Presentation CATCH-UP 2015

LVAD State of the Field

Presenter: Paolo C. Colombo

April 24, 2015

Presentation TCT 2014

LVADs for Chronic Heart Failure - Lessons Learned from HMII, HVAD, Jarvik, and Others

Presenter: John C Criscione, Elmir Omerovic, Bartley P. Griffith

September 16, 2014

Presentation TCT 2014

Advanced Heart Failure Therapies in 2014: LVAD or Transplant?

Presenter: Finn Gustafsson

September 16, 2014

Presentation TCT 2013

LVAD Complications State-of-the-Art: Current Status on Thrombosis, Stokes, Bleeding and Arrhythmias

Presenter: Keith Aaronson

October 28, 2013

Presentation TCT 2012

Contemporary LVAD Therapy: Destination, Recovery, Bridge?

Presenter: Emma Birks

October 23, 2012

Advertisement

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

Right Heart Failure After LVAD

LVAD State of the Field

LVADs for Chronic Heart Failure - Lessons Learned from HMII, HVAD, Jarvik, and Others

Advanced Heart Failure Therapies in 2014: LVAD or Transplant?

LVAD Complications State-of-the-Art: Current Status on Thrombosis, Stokes, Bleeding and Arrhythmias

Contemporary LVAD Therapy: Destination, Recovery, Bridge?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content